Study uncovers proteomic signatures in blood plasma and cervicovaginal fluid that could lead to non-invasive detection methods for endometrial cancer, demonstrating significant potential for early diagnosis and improved patient outcomes.
Novo to buy mid-stage heart failure biotech Cardior for up to $1.1B
Novo Nordisk plans to acquire German biotech Cardior Pharmaceuticals, a Phase 2 RNA startup, for up to $1.1 billion to boost its presence in cardiovascular disease, the